| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
82,270,000 |
| Market
Cap: |
273.14(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.29 - $35.72 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.1 |
| Insider 6 Months : 8.1 |
| Insider 3/6 Months : 16.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL™ Relational Commerce Platform and HintMD platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
30,000 |
30,000 |
30,000 |
30,000 |
| Total Buy Value |
$209,400 |
$209,400 |
$209,400 |
$209,400 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
29,089 |
29,089 |
291,945 |
446,160 |
| Total Sell Value |
$143,717 |
$143,717 |
$7,898,916 |
$12,719,522 |
| Total People Sold |
4 |
4 |
5 |
5 |
| Total Sell Transactions |
4 |
4 |
17 |
27 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ruegg Curtis |
EVP, Technical Operations |
• – – |
2016-03-07 |
4 |
OE |
$8.70 |
$8,700 |
D/D |
1,000 |
26,264 |
|
- |
|
| Byrnes Robert F |
Director |
– • – |
2016-02-12 |
4 |
OE |
$2.55 |
$44,247 |
D/D |
10,999 |
10,999 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
25,264 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
243,677 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2016-02-08 |
4 |
AS |
$18.14 |
$18,140 |
D/D |
(1,000) |
17,264 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2016-02-08 |
4 |
OE |
$8.70 |
$8,700 |
D/D |
1,000 |
18,264 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2016-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,695 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2016-01-28 |
4 |
D |
$20.30 |
$21,579 |
D/D |
(1,063) |
21,695 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2016-01-28 |
4 |
D |
$20.30 |
$15,489 |
D/D |
(763) |
17,264 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2016-01-06 |
4 |
AS |
$33.06 |
$66,120 |
D/D |
(2,000) |
18,027 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2016-01-06 |
4 |
OE |
$8.70 |
$17,400 |
D/D |
2,000 |
20,027 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2015-12-31 |
4 |
A |
$27.00 |
$9,153 |
D/D |
339 |
22,758 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2015-12-31 |
4 |
A |
$27.00 |
$7,074 |
D/D |
262 |
218,677 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2015-12-30 |
4 |
OE |
$2.55 |
$30,715 |
D/D |
12,045 |
218,415 |
|
- |
|
| Joshi Abhay |
Chief Operating Officer |
• – – |
2015-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
34,375 |
34,375 |
|
- |
|
| Bertolino Arthur Peter |
EVP and Chief Medical Officer |
• – – |
2015-11-17 |
4 |
S |
$39.11 |
$303,242 |
D/D |
(7,753) |
34,001 |
|
- |
|
| Bertolino Arthur Peter |
EVP and Chief Medical Officer |
• – – |
2015-09-02 |
4 |
D |
$30.48 |
$112,746 |
D/D |
(3,699) |
41,754 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-08-17 |
4 |
AS |
$30.13 |
$90,990 |
D/D |
(3,000) |
18,027 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-08-17 |
4 |
OE |
$8.70 |
$26,100 |
D/D |
3,000 |
21,027 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-07-17 |
4 |
AS |
$31.03 |
$93,090 |
D/D |
(3,000) |
18,027 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-07-17 |
4 |
OE |
$6.60 |
$22,244 |
D/D |
3,000 |
21,027 |
|
- |
|
| Silvernail Lauren P |
CFO, Secretary & EVP Corp Dev. |
• – – |
2015-06-30 |
4 |
A |
$14.16 |
$8,963 |
D/D |
633 |
633 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2015-06-30 |
4 |
A |
$14.16 |
$14,160 |
D/D |
1,000 |
1,000 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-06-17 |
4 |
AS |
$33.53 |
$100,593 |
D/D |
(3,000) |
18,027 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-06-17 |
4 |
OE |
$6.60 |
$19,800 |
D/D |
3,000 |
21,027 |
|
- |
|
422 Records found
|
|
Page 14 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.97 (22.61%) 
